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Background: Genetic aberrations are required for the progression of HPV-induced cervical precancers. A
prerequisite for clonal expansion of cancer cells is unlimited proliferative capacity. In a cell culture model for cervical
carcinogenesis loss of genes located on chromosome 4q35→qter and chromosome 10p14-p15 were found to be
associated with escape from senescence. Moreover, by LOH and I-FISH analyses a higher frequency of allele loss of
these regions was also observed in cervical carcinomas as compared to CIN3. The aim of this study was to identify
candidate senescence-related genes located on chromosome 4q35→qter and chromosome 10p14-p15 which may
contribute to clonal expansion at the transition of CIN3 to cancer.
Methods: Microarray expression analyses were used to identify candidate genes down-regulated in cervical
carcinomas as compared to CIN3. In order to relate these genes with the process of senescence their respective
cDNAs were overexpressed in HPV16-immortalized keratinocytes as well as in primary human fibroblasts and
keratinocytes using lentivirus mediated gene transduction.
Results: Overall fifteen genes located on chromosome 4q35→qter and chromosome 10p14-p15 were identified.
Ten of these genes could be validated in biopsies by RT-PCR. Of interest is the novel finding that SORBS2 and TLR3
can induce senescence in primary human fibroblasts and keratinocytes but not in HPV-immortalized cell lines.
Intriguingly, the endogenous expression of both genes increases during finite passaging of primary keratinocytes
in vitro.
Conclusions: The relevance of the genes SORBS2 and TLR3 in the process of cellular senescence warrants further
investigation. In ongoing experiments we are investigating whether this increase in gene expression is also
characteristic of replicative senescence.
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Lentiviral mediated gene transductionBackground
One of the inherent properties of high-risk human papil-
lomavirus (HR-HPV) types belonging to the α-genus of
the Papillomaviridae is their ability to immortalize pri-
mary human epithelial cells. In pioneering experiments
conducted in the late eighties it was shown that transfec-
tion of the native HPV16 or HPV18 genomes could ex-
tend the proliferative life-span of foreskin keratinocyte
cultures. After a phase of crisis, immortal cell clones* Correspondence: claudia.backsch@med.uni-jena.de
1Department of Gynecology, Jena University Hospital, Friedrich Schiller
University Jena, Bachstr. 18, Jena 07743, Germany
Full list of author information is available at the end of the article
© 2013 Liesenfeld et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the orwould emerge from most of these cultures [1,2]. In sub-
sequent experiments the viral proteins driving the
immortalization process were identified [3,4]. The onco-
proteins E6 and E7 interact with numerous cell regula-
tory proteins, most notably with p53 and pRb
respectively, thereby deregulating the cell cycle, DNA re-
pair and apoptosis which inevitably leads to genetic
instability [5,6]. Indeed, the inactivation of the p16INK4A-
Rb pathway has more recently been identified to play a
critical role in cellular senescence [7,8]. However,
bypassing one of the regulatory pathways for senescence
is not sufficient for immortal cell growth. Several add-
itional genetic alterations including the activation ofral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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atic cell fusion experiments suggest that the immortal
phenotype can be complemented and thereby implies
loss of gene function as a characteristic step in this
process [10,11]. In our previous studies using microcell-
mediated chromosome transfer into HPV-immortalized
cells we provided functional evidence for senescence as-
sociated genes located on chromosomal regions 10p14-
15 and 4q35→qter [12,13]. Importantly, these regions
are more frequently affected by allele loss in cervical car-
cinomas than precancers [12-14] and thus warranted a
more detailed investigation. In order to identify candi-
date genes which contribute to senescence we had in
earlier experiments performed microarray expression
analyses with a particular focus on the above chromo-
somal regions. Two genes were found to be significantly
down-regulated in cervical cancers as compared to pre-
cancers (CIN3). However, ectopic expression of neither
gene could induce senescence in HPV-transformed cells
[15]. A possible weakness of that study may have been
the use of pooled RNA for the array experiments which
may have masked differences in the expression levels of
several genes. In the present study we have therefore
modified our strategy. Instead of pooled RNA, RNA
from 12 microdissected CIN3 and 11 cervical carcin-
omas were used for individual expression analyses. Ten
out of 15 genes which were found to be significantly
down-regulated in cervical cancers versus CIN3 could
be validated by quantitative RT-PCR and showed highly
significant differences in expression between the two
groups. Of seven genes cDNAs were overexpressed in
HPV-immortalized cell lines, primary fibroblasts or pri-




Biopsies of histopathologically confirmed CIN3 and
squamous cell carcinoma (CxCa) from patients at the
Department of Gynaecology at the Jena University
Hospital were available for this study. This study was ap-
proved by the Ethics Committee of the Friedrich-
Schiller-University Jena (reference number: 1402-09/04).
Informed consent for the use of residual tissue for re-
search was given. All cases were HPV-16 positive.
Biopsies were embedded in Tissue-Tek (Sakura Finetek
Germany GmbH, Staufen, Germany) and stored at −
80°C. Sectioning was performed using a cryo-microtome
(Shandon cryotome SME, Thermo Fisher Scientific,
Wilmington, USA). Sections of 12–15 μm thickness
were prepared. To protect the RNA from degradation,
all instruments used for RNA isolation were treated with
RNaseZap (Ambion/Applied Biosystems, Darmstadt,
Germany) and rinsed with DEPC-water. Sections wereplaced on pre-cooled PALM MembraneSlides NF
(RNase- and DNase-free; PALM Microlaser Technology,
Bernried, Germany) which were treated with UV-light
for 30 min thereby allowing better adhesion. The slides
were quickly dried on a thermoplate at 40°C to protect
tissue and RNA from humidity. Tissue-Tek medium in-
terferes with the laser beam during microdissection and
was therefore removed by washing the slides in 70%
ethanol followed by drying on a thermoplate.
Laser capture microdissection
Immediately before microdissection the tissue sections
were stained with a 1%-solution of Cresyl Violet acetate
(minimum dye content 70%, Sigma-Aldrich, Seelze,
Germany) in 96% ethanol for 1 min, differentiated with
70% ethanol and dried on a heating plate. Microdissec-
tion and pressure catapulting of tumor or dysplastic
areas were performed on a PALM MicroBeam (Zeiss,
Jena, Germany). The specimens were collected in PALM
AdhesiveCaps 500 opaque (PALM Microlaser Technolo-
gies, Bernried, Germany).
RNA isolation, RNA quality and integrity assessment
The microdissected samples were dissolved in 400-500 μl
TRIzol reagent (Invitrogen, Karlsruhe, Germany) and
mixed with 0.33 volumes of chloroform. For a clear separ-
ation of the aqueous and organic phase the TRIzol-
Chloroform solution was centrifuged at 14000 rpm for
20 min at 4°C in Phase Lock Gel Heavy tubes (Eppendorf,
Hamburg, Germany). The aqueous phase was collected
and mixed with 2 volumes of 70% ethanol. Total RNA
was extracted with the RNeasy Micro Kit (QIAGEN,
Hilden, Germany) according to the manufacturer’s in-
structions (which include DNase digestion) and was
eluted in 14 μl RNase-free water. To assess the concen-
tration of the total RNA, 1 μl was directly measured on
a NanoDrop spectrophotometer (ND-1000, NanoDrop
Technologies, Thermo Fisher Scientific, Wilmington,
USA). The integrity of the RNA was determined using a
2100 Bioanalyzer (Agilent Technologies, Waldbronn,
Germany) thus enabling quality comparison to be made
between the samples. The median RIN (RNA integrity
number) of the RNA samples, which were hybridised to
microarrays, was 6.2 (+/− 1.12).
Microarray hybridization and data analysis
Finally, RNA from 12 microdissected CIN3 and 11 CxCa
were used for Agilent Whole Human Genome Oligo
Microarray (4 × 44 K slide) hybridization in one-colour
experiments with Cy3-labeled samples. Reverse tran-
scription into cDNA, labeling of cDNA, hybridization
and scanning of the microarrays were done according to
the manufacturers’ protocols. Quality control was per-
formed with the Feature Extraction Software by Agilent.
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sion values were normalized to the median. Genes with
expression values over 20 were set as expressed. Further
gene analyses were performed with the software Gene-
Spring from Agilent. For group comparison the Welch
t-test with a p-value cut-off of 0.05 was applied, followed
by a multiple testing correction according to Benjamini
and Hochberg [16].
Validation with real-time PCR (qPCR)
The microarray data of all candidate genes was validated
by reverse transcription qPCR. For this purpose the
remaining RNA from the array analyses and from fur-
ther microdissected biopsies, altogether 20 CIN3 and 20
CxCa, were used. All cases were HPV16-positive.
200 ng RNA of each sample was reverse transcribed in
a total volume of 40 μl using SuperScript II Reverse
Transcriptase (Invitrogen, Karlsruhe, Germany) accord-
ing to the manufacturers’ protocol. Quantitative PCR
was done with an ABI 7300 SDS system (Applied Biosys-
tems, Darmstadt, Germany) using the PowerSybrGreen
Master Mix (Applied Biosystems, Darmstadt, Germany).
Reactions were performed with cDNA equivalent to
5 ng RNA in a volume of 25 μl volume comprising
gene-specific forward and reverse primers (10pmol each)
(Additional file 1: Table S1). To determine the normal-
isation factor (NF) we used the three most stable house-
keeping genes (HKGs) GAPDH, HPRT and ACTB, which
were identified by the method of Vandesompele and col-
leagues [17]. PCR data were analysed using REST (rela-
tive expression software tool) [18].
Amplification, cloning and sequencing of cDNA
To generate expression-constructs of the genes of inter-
est we used cDNA-clones available from ImaGenes
(Berlin, Germany) (Additional file 2: Table S2). The cod-
ing sequences were amplified with the Long Expand
Template PCR-System (Roche, Mannheim, Germany).
The PCR comprised dNTP’s (350 μM), forward and re-
verse primers (300 nM), 1× buffer, plasmid-DNA (10 ng),
enzyme-mix (3.75 U). The following PCR cycling parame-
ters were employed: 94°C for 2 min initial denaturation,
followed by 10 cycles at 94°C for 10 s, annealing
temperature according to Table S3 (Additional file 3:
Table S3) for 30 s, elongation at 68°C for 2 min. The next
20 cycles consisted of 94°C for 15 s, 65°C for 30 s, 68°C
for 2 min with an additional increase of 20 s at 68°C for
every cycle. The PCR products were separated on 2%
agarose gels and the bands of predicted size were excised.
DNA was eluted with Zymoclean Gel DNA Recovery Kit
(Zymo research, Orange, USA) following the manufac-
turers protocol. PCR-products were cloned into pJet
using the CloneJET PCR Cloning Kit (Fermentas, St.
Leon-Rot, Germany) following the manufacturer’sinstructions and transformed into E.coli XL1-Blue. Sub-
cloning into the lentiviral vector pCDH-CMV-MCS-EF1-
Puro (#CD510B-1, BioCat, Heidelberg, Germany) was
done via the restriction enzymes shown in Table S4
(Additional file 4: Table S4). The ligation reaction con-
sisted of: 50 ng pCDH-vector; 3U Ligase (Fermentas, St.
Leon-Rot, Germany); 2 μl 10× buffer and 10 ng DNA-
fragment in a total volume of 20 μl. The mix was incu-
bated at 14°C for 16 h and then cloned into E.coli Stbl3
(Invitrogen, Karlsruhe, Germany). To ensure functional-
ity all constructs were sequenced at Seqlab (Göttingen,
Germany) (Additional file 5: Table S5).Cell culture
For functional studies, the following cell lines were used:
HPKIA and HPKII (both HPV16-immortalized human
keratinocytes at passages p83 and p289, respectively)
[19,20], CaSki and SiHa (both HPV16-positive cervical
carcinoma), HeLa, SW756 and C4.I (all HPV18-positive
cervical carcinoma). All cervical carcinoma cell lines
were obtained from the ATCC. Primary human keratino-
cytes and fibroblasts were isolated from foreskins of four
donors. Primary keratinocytes were cultured in EpiLife
(Cascade Biologics, Portland, USA) with human kera-
tinocyte growth supplement (HKGS, Cascade Biologics,
Portland, USA). All other cell lines were grown in
Dulbecco’s modified Eagle medium (D-MEM; Gibco
Invitrogen, Karlsruhe, Germany) supplemented with 10%
fetal calf serum (FCS), 100 U/ml penicillin and 100
μg/ml streptomycin at 37°C with 5% CO2.Lentivirus production
For the generation of recombinant lentivirus particles
HEK 293 T cells were transfected using the calcium
phosphate-method. One day before transfection 1.8×106
cells were seeded into a 6 cm-plate to achieve 80-90%
confluence by the next day. The transfection mix com-
prising CaCl2 and BES-buffered saline, 2 μg pCDH ex-
pression plasmid, 2 μg pMDL, 1 μg pRSV and 0.4 μg
pVSV-g was dropped onto the cells into 3 ml D-MEM
(+10% FCS) and cultured over night at 35°C and in 3%
CO2. The next day the cells were washed 2× with PBS
and cultured over night with 3 ml medium at 32°C and
in 5% CO2. About 48 h after transfection the virus-
containing medium could be harvested. A 3rd gener-
ation packaging system with plasmid pMDLg/pRRE
(included HIV-1 gag/pol genes; gag, coding for the vir-
ion main structural proteins; pol, responsible for the
retrovirus-specific enzymes; RRE, a binding site for the
Rev protein), plasmid pRSV-Rev (included parts of HIV-
1 rev gene, controlling the export rate of mRNAs) and
plasmid pCMV-VSVG (envelope plasmid) were used to
produce lentiviral particles.
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One day before transduction the target cells were seeded
into 12-well-plates at a density of 1×106 cells/well.
Virus-containing medium was harvested and filtered
through a 0.45 μm filter. For each well 1 ml of virus-
containing medium was mixed with 2 μg Polybrene
(stock 5 mg/ml; Sigma-Aldrich, Steinheim, Germany) to
replace the culture medium. Transduction was per-
formed twice on the first day, temporally separated by
6 h, and a third time on the next day. Polybrene was
used only for the first transduction. After adding the
virus-containing medium the plates were centrifuged at
1500 rpm for 45 min at RT and subsequently cultured at
32°C and in 5% CO2 in the incubator. Six hours after the
third transduction the virus-containing medium was re-
moved and replaced with unmodified culture medium
and the cells were cultured under normal conditions.
For establishing stable clones selection was performed
with 0.5 μg - 1 μg/ml puromycin hydrochlorid (Sigma-
Aldrich, Steinheim, Germany) for 5–7 days. Assays were
done in triplicate and repeated four times.
β-galactosidase assay
After removing the culture medium, cells were washed
in PBS and fixed in a 3% formaldehyde solution for
5 min at RT. Cells were washed again with PBS and in-
cubated with fresh senescence-associated β-galactosidase
(SA-β-gal) solution as described by Dimri and colleagues
[21]. Incubation was performed at 37°C over night.
Northern blot
Northern blotting was done according to a standard
protocol. Approximately 4 μg of total RNA were sepa-
rated in a 1% MOPS- agarose gel and blotted onto a
nylon membrane. Radioactively labeled DNA probes
were generated by random priming (Roche Applied Sci-
ence, Mannheim, Germany) with [32P]-ATP (Hartmann
Analytic GmbH, Braunschweig, Germany). For removal
of non-integrated nucleotides G-50 Sephadex-columns
(Roche Applied Science, Mannheim, Germany) were
used. Hybridization was performed for 2–3 days at 42°C
followed by stringent washing and exposition to X-ray
films for 3-14d at −80°C.
Immunofluorescence
1×105 cells suspended in 150 μl PBS were centrifuged at
500 rpm for 2 min at RT onto a glass slides. After fix-
ation with 4% paraformaldehyde for 10 min, slides were
washed with Tris-buffered solution (50 mM Tris,
150 mM NaCL) with 0,1% Tween-20 (TBST). Slides
were then blocked with 50 μl normal serum (donkey-
serum for SORBS2- and goat-serum for p16INK4a- anti-
body, respectively)(each 1:5 dilution in TBST) for
20 min at RT. Primary antibodies specific for SORBS2(ArgBP2 H-15, Santa Cruz Biotechnologies, Heidelberg,
Germany) (dilution 1:200) or p16INK4A (Roche mtm La-
boratories, Heidelberg, Germany) (dilution 1:2) were then
applied and incubated over night at 4°C followed by 3
washing steps with 1× TBST for 5 min each. Incubation
with the secondary antibody for SORBS2 staining (donkey
anti-goat IgG-FITC sc-2024, 1:100; Santa Cruz Biotech-
nologies, Heidelberg, Germany) was done for 45 min at
RT. Afterwards slides were washed again 3 times for
5 min with washing buffer, rinsed with aqua bidest and
covered with antifade/DAPI-solution under a coverslip.
P16INK4a -detection was performed using EnVision™ De-
tection System Rabbit/Mouse (Dako Deutschland GmbH,
Hamburg, Germany) according to the manufacturers
protocol. Slides were then counterstained with hema-
toxylin and covered with coverslips in gelatine. Fluores-
cence or brightfield images were obtained with a Zeiss
Axioplan 2 microscope and a Axio Cam HRc using 20×
and 40× objectives using AxioVision Application Rel.4.5.2,
(Zeiss, Jena, Germany).
Western blot
Western blotting was done according to a standard proto-
col for semi dry procedure. Cells growing in a 6 cm dish
were lysed in 300 μl of 1% SDS solution with 1:100 protein
inhibitor (Serva Electrophoresis, Heidelberg, Germany).
Approximately 10-15 μg protein was separated by 10%
SDS-PAGE and transferred to an Immobilon-P membrane
(Millipore, Bedford, USA). For immunostaining antibodies
specific for SORBS2 (ArgBP2 H-15 goat, 100 ng/ml, Santa
Cruz Biotechnologies, Heidelberg, Germany), TLR3 (TLR3
L-13, N-14 and Q-18, each goat IgG, 200 ng/ml, Santa Cruz
Biotechnologies, Heidelberg, Germany) and ACTB (ACTB
mouse, 125 ng/ml, BD Bioscience, Heidelberg, Germany)
were used. The secondary antibodies were labelled with
horseradish peroxidase (HRP) (anti-rabbit 0.04 ng/ml, anti-
goat 0.08 ng/ml, anti-mouse 0.04 ng/ml; Dianova,
Hamburg, Germany). The first antibodies were incubated
over night at 4°C and the second antibodies for 1 h at RT.
A 5% milk solution was used for blocking. All antibodies
were diluted in 1% BSA solution. Staining was visualized
using enhanced chemiluminescence (SuperSignal West
Pico Chemiluminescent Substrate, Thermo Fisher Scien-
tific, Dreieich, Germany).
Results
Identification of senescence-associated genes by
microarray analyses
For microdissection only biopsies with large cohering
tumor areas, a low amount of lymphocyte infiltrates and
sharp-cut borderlines to stroma were chosen. Overall 35
CIN3 and 64 CxCa were microdissected and RNA was iso-
lated. Of these 12 CIN3 and 11 CxCa yielded RNA with an
integrity number (RIN) of ≥5 and a concentration of 25 ng/μl
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for microarray analyses. Evaluation of the microarrays pri-
marily focussed on the chromosomal regions 4q35→qter
and 10p14-15 for which we have functional evidence for
the location of tumour suppressor genes [12,13]. Because
only 85 (4q35→qter) and 95 (10p14-15) genes are located
within these regions the threshold level indicative for dif-
ferences in gene expression was lowered to 1.3 which is
below the standard value of 2. Overall 15 genes were
found to be significantly down-regulated in cervical can-
cers versus CIN3 (Table 1).
Validation of senescence-associated genes by RT-PCR
Ten genes could be validated by quantitative RT-PCR and
showed highly significant differences in expression between
the two groups (Table 1). The validation set comprised not
only RNA of the biopsies used for array analyses but also
an additional set of 8 CIN3 and 9 CxCa. Of note is, that
with exception of PFKFB3 the differences in gene expres-
sion remained highly significant even when evaluation was
based solely on the independent set of RNAs (Additional
file 6: Table S6). For five of the 15 genes reliable RT-PCR
assays could not be established and were therefore not pur-
sued further at this stage. Relative gene expression levels of
SORBS2 and TLR3 in CIN3 and CxCa are shown in
Figure 1 and for all other genes in Figure S1 (Additional
file 7: Figure S1).
Ectopic expression of candidate genes
The effect of ectopic expression of SORBS2, TLR3,
CYP4V2, FBXO18, IL15RA, WDR37 and DIP2C on theTable 1 Down-regulated genes located on 4q35 and 10p14-1
Agilent-Nr Gene
A_23_P104413 double homeobox, 4
A_23_P121795 sorbin and SH3 domain containing 2
A_23_P140884 tubulin, beta polypeptide 4, member Q
A_23_P29922 toll-like receptor 3
A_23_P358470 coiled-coil domain containing 111
A_23_P58180 cytochrome P450, family 4, subfamily V, polypeptide 2
A_23_P104252 inter-alpha (globulin) inhibitor H5
A_23_P12849 F-box protein, helicase, 18
A_23_P1374 protein kinase C, theta
A_23_P138680 Interleukin 15 receptor, alpha
A_23_P47073 WD repeat domain 37
A_23_P75056 GATA binding protein 3
A_24_P111096 6-phospho-fructo-2-kinase /fructose-2,6-bisphosphatase
A_24_P242705 tRNA aspartic acid methyl-transferase 1
A_24_P360722 DIP2 disco-interacting protein 2 homolog C (Drosophila)
n.d. – not determined.cell phenotype, in particular senescence, was investigated
in primary cells, HPV-immortalized cells and cervical
carcinoma cells. PFKFB3 was not pursued further be-
cause down-regulation could not be validated in an inde-
pendent set of biopsies (Additional file 6: Table S6).
All cDNAs were cloned into the pCDH vector for
lentivirus mediated gene transduction (Additional file 2:
Table S2). For two candidate genes, PRKCQ and GATA3
the cDNA clones were erroneous. The empty vector
served as negative control in all experiments. Two differ-
ent splice variants were used for SORBS2. Both splice
variants (SORBS2-1 and SORBS2-2) code for the SoHo
domain at the N-terminus and the three major SH3-
domains at their COOH-terminal region.
All candidate genes were ectopically expressed in pri-
mary keratinocytes and fibroblasts and in the HPV16-
immortalized keratinocyte cell lines HPKIA p83 and
HPKII p289. Overall these two cell lines showed the
lowest endogenous expression of the genes to be ana-
lysed (Table 2). Selection was done with puromycin.
Stable expression over at least five passages was con-
firmed by Northern blots and in case of SORBS2 also by
Western blot (Figure 2, Additional file 8: Figure S2 and
Additional file 9: Figure S3).
None of the genes could induce senescence in HPV-
immortalized cells and cervical carcinoma derived cell lines
All seven candidate genes were ectopically expressed in
HPKIA p83 and HPKII p289 cells. In addition, their in-
fluence in SiHa cells and SW756 cells was also exam-
ined. Three days post transduction the cells were seeded5
Symbol Chromosome
Expression Array Real-time PCR
Ratio CIN3/CxCa (p-value)
DUX4 4q35 -1.92 (0.0382) n.d.
SORBS2 4q35.1 -1.83 (0.0487) -31.709 (<0.001)
TUBB4Q 4q35 -1.76 (0.0409) n.d.
TLR3 4q35 -2.3 (0.0024) -6.437 (<0.001)
CCDC111 4q35.1 -1.56 (0,0213) n.d.
CYP4V2 4q35.2 -1.96 (0.0446) -6.144 (<0.001)
ITIH5 10p14 -4.14 (0.0301) n.d.
FBXO18 10p15.1 -1.34 (0.0228) -2.445 (<0.001)
PRKCQ 10p15 -3.69 (0.0428) -8.048 (<0.001)
IL15RA 10p15-p14 -1.68 (0.00312) -2.973 (<0.001)
WDR37 10p15.3 -1.39 (0.0355) -4.676 (<0.001)
GATA3 10p15 -1.5 (0.0222) -30.061 (<0.001)
PFKFB3 10p14-p15 -1.69 (0.017) -1.971 (0.0174)
TRDMT1 10p15.1 -1.55 (0.0238) n.d.





Figure 1 SORBS2 and TLR3 expression in CIN3 and cervical
carcinomas (CxCa). Relative gene expression of SORBS2 (A) and
TLR3 (B) was determined by quantitative RT-PCR in CIN3 (n = 20)
and CxCa (n = 20). For normalisation the housekeeping genes
GAPDH, HPRT and ACTB were used. Both genes were expressed at
highly significant (p < 0.001) lower levels in CxCa than in CIN3 (A, B).
Table 2 Relative expression of candidate genes in different ce
Gene SORBS2 TLR3 CYP4V2
cell line
HPKIAp83 -125301 -76 -400
HPKIAp359 -19415 -48 -316
HPKIIp54 -30612 -223 -905
HPKIIp289 -51328 -504 -1560
CaSki -678 -190 -1603
SiHa -56208 -515 -872
HeLa -345 -248 -631
SW756 -3674 -234 -1299
C4.1 -1881 -35 -364
Calculation is based on the formula: -1/2(Ct mean housekeeping genes – Ct gene of interest).
The lowest expression values are shown in bold.
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at different time points up to 3 weeks. Staining was per-
formed whenever the cultures reached 80-90% conflu-
ence. To monitor induction of senescence over this time
span the cells needed to be sub-cultured whenever con-
fluence was reached. No differences in cell growth were
noted when cells transduced with the gene of interest
and the empty vector (pCDH) were compared. All trans-
ductants were selected for puromycin resistance and
were passaged beyond 6 weeks before being frozen for
storage. Senescence above background was not observed
in any of the experiments conducted (Additional file 8:
Figure S2).
SORBS2 and TLR3 could induce senescence in primary
fibroblasts and keratinocytes
We then decided to investigate whether the candidate
genes could induce senescence in primary human fore-
skin fibroblasts and keratinocytes. Low passage cells (p2)
were transduced in the same manner as immortal cell
lines. The highest number of senescent cells was ob-
served for SORBS2-2 fourteen days after transduction.
Thereafter, the number of senescent cells decreased
most likely due to the lack of detachment or reattach-
ment of senescing cells during sub-culturing. The char-
acteristic perinuclear β-galactosidase staining pattern of
enlarged and flattened cells was observed in case of fi-
broblasts (Figure 2). In contrast, the morphology of sen-
escing keratinocytes differed in that both enlarged and
rounded cells with an overall blue stain were observed
(Figure 2). Senescence was scored positive if the number
of β-galactosidase stained cells was ≥ 2-fold (+) or ≥ 4-
fold (++) higher as compared to empty vector.
Altogether fibroblasts were more responsive for senes-
cence than keratinocytes (Table 3). SORBS2-2 and TLR3
could induce senescence in both cell types whereas for
SORBS2-1 the effect was restricted to fibroblasts.ll lines
FBXO18 IL15RA WDR37 DIP2C
-62 -97 -80 -1006
-48 -37 -47 -178
-134 -129 -149 -509
-120 -430 -122 -457
-97 -85 -158 -409
-33 -55 -71 -139
-20 -13 -66 -348
-56 -35 -154 -165












Figure 2 Induction of senescence after ectopic expression of SORBS2 in primary fibroblasts and keratinocytes. Beta-galactosidase
staining was performed at different time points after lentiviral transduction. Depicted are cells stained 14 days after transduction of pCDH empty
vector (control) and SORBS2-2. Only a few senescent cells (arrows) are evident in the control (A). An at least 4-fold increase in senescent cells is
observed after transduction of SORBS2 both in primary human fibroblasts and keratinocytes (B). All images were captured at 200× magnification.
Expression of the transgene in cells at same passage was confirmed by Western blot (C).
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cence in fibroblasts only but the results of four inde-
pendent experiments were inconsistent.
Endogenous levels of SORBS2 and TLR3 increase during
in vitro passaging of primary keratinocytes
The life span of primary keratinocytes in culture is short.
Normally the cells reach a phase of crisis within 10 pas-
sages. This is in sharp contrast to fibroblasts which can
easily be passaged 50 times and more before entering
crisis. Since SORBS2-2 and TLR3 can induce senescence
after ectopic expression in primary keratinocytes we
were curious to evaluate the endogenous expression of
these genes during finite passaging of keratinocytes. Ex-
pression levels were determined by quantitative RT-PCR
and in case of SORBS2 also by immunocytochemistry.
Increased p16INK4a expression, a hallmark of senescing
cells, was monitored in parallel. Primary cultures at the
earliest available passage (p2) expressed very low relativelevels of SORBS2 and TLR3 which could be detected by
qRT-PCR but not by Northern blots or immunocyto-
chemistry (data not shown). In subsequent passages a
strong increase in endogenous expression of SORBS2
and TLR3 was observed in 3 primary keratinocytes cul-
tures from different donors. Exemplarily, immunostain-
ing for SORBS2 and p16INK4a and qRT-PCR for TLR3 at
passage 5 and 7 are shown in Figures 3 and in
Additional file 10: Figure S4, respectively. Strong en-
dogenous expression of p16INK4a, SORBS2 and TLR3
correlated with a near senescent stage of the cells.
Discussion
Escape from senescence is a prerequisite for carcinogen-
esis. Our previous functional studies involving somatic
cell fusions and micro-cell mediated chromosome trans-
fers have linked recessive gene alterations with the ac-
quisition of immortality [12,13,22]. In this study we have
identified and validated 10 genes located within the
Table 3 Summary of the investigated genes and their
influence on senescence in primary fibroblasts and





CYP4V2 + / - -




-no differences between expression of the gene and pCDH (empty vector).
+ / -≥ 2-fold number of senescent cells in comparison to the empty vector,
but inconsistent between experiments.
+≥ 2-fold number of senescent cells in comparison to the empty vector.
++≥ 4-fold number of senescent cells in comparison to the empty vector.
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http://www.biomedcentral.com/1471-2407/13/507chromosomal regions 4q35→ qter and 10p14-p15 that
were down-regulated in cervical cancer as compared to
CIN3. Down-regulation of SORBS2, TLR3 and GATA-3
has already been described in the context of cervical car-
cinogenesis. SORBS2 was shown to be expressed in nor-
mal cervical epithelium and CIN3 but at significantly
reduced levels in CxCa [15]. Immunhistochemical ana-
lysis for GATA-3 showed a clear nuclear staining in nor-
mal cervical squamous epithelium, CIN1 and CIN2
lesions, but 11% of CIN3 and 67% of CxCa revealed a
complete absence of GATA-3 immunostaining [23].
TLR3, a toll-like receptor eliciting an antiviral response
in the presence of HPV oncogene expression, is in-
creased in CIN3 followed by a decrease in CxCa [24].
The remaining 7 genes with exception of PFKFB3 are
not linked to cancer when reviewing the literature.
PFKFB3, in particular the splice variant UBI2K4 is con-
sidered to be a tumor suppressor protein in glioblast-
omas [25].
None of the above genes have thus far been associated
with the loss of senescence. We had expected that reconsti-
tution of gene expression in HPV-immortalised keratino-
cyte cell lines such as HPKIA and HPKII or cervical
carcinoma derived cell lines would induced senescence.
However, this was not the case and leaves room for specu-
lation. In previous analyses using micro-cell mediated
transfer either of the entire chromosome 4 or 10 resulted
in senescence of HPKII cells. In subsequent studies using
derivative of chromosomes 4 and 10 the chromosomal re-
gion harbouring putative senescence genes were narrowed
down by exclusion [12,13]. In other words none of the de-
rivative chromosomes could induce senescence. It is there-
fore conceivable that a candidate senescence gene is indeed
located within this region but to exert its effect on senes-
cence the product of another gene located on the same
chromosome is required. If this gene is lacking, ectopicexpression of the senescence gene itself will have no effect.
We have therefore ectopically expressed the candidate
genes in primary human keratinocytes and fibroblasts
which should not have any genetic aberrations. Of the
seven candidate genes only SORBS2-2 and TLR3 could re-
producibly induce senescence both in fibroblasts and kera-
tinocytes. SORBS2-1, a shorter splice variant of SORBS2,
could only induce senescence in fibroblasts. The reason for
this phenomenon is unclear. Both isoforms encode relevant
functional parts of the protein such as the SoHo (Sorbin
homology) and the three SH3 (Src homology 3) domains at
the amino and carboxyl terminal end, respectively.
Clearly, the type of senescence observed in this study
is not to be confused with proliferative senescence which
results when telomeres have reached a critical minimal
length and thereby have lost their protective structure.
Senescence can also be induced in the absence of telo-
mere shortening or dysfunction by a variety of condi-
tions. This phenomenon is referred to as premature
senescence and is either induced by stress as a conse-
quence of suboptimal culturing conditions [26], or by el-
evated oncogene expression [9]. Indeed, aberrant
activation of signal transduction pathways and promot-
ing cell cycle regulators can result in a DNA-damage
response (DDR) and thereby induce premature senes-
cence. In this context the role of c-Abl in DNA repair
may be helpful to understand our finding that SORBS2
can induce senescence. SORBS2 interacts with poly-
proline motifs of c-Arg and c-Abl kinases via its three
SH3 domains. A complex of the ubiquitin ligase Cbl
and SORBS2 mediates the ubiquitination and degrad-
ation of c-Abl [27]. Within this complex, SORBS2 acts
as a regulator of ubiquitination and degradation of
c-Abl. It remains to be shown if this pathway is relevant
for premature senescence. At a first glance the associ-
ation between TLR3 and senescence may be interpreted
as a lentivirus induced phenomenon. TLR3 is a member
of the toll-like receptor family involved in the response
of the innate immune system to pathogens such as
double-stranded RNA viruses [28]. TLR3 activation re-
sults in the induction of intracellular pathways mediated
by NF-қB and MAPK and can lead to IFN-beta and
TNF-alpha gene expression [29,30]. Furthermore, NF-қB
activation can lead to the production of proinflamma-
tory cytokines expression such as IL-1 and apoptosis
[28] or IL-1 and IFN-beta induced senescence [31,32].
We can therefore not completely exclude that the senes-
cence observed in the TLR3 encoding lentivirus infected
primary cells reflects a bias of the expression system.
However, it should be considered that the very same
recombinant virus could not induce senescence in
HPV16-immortalized HPK cells. Moreover, the “empty”
virus which served as negative control in all experi-












Figure 3 Endogenous expression of SORBS2 and p16INK4A during in vitro passaging of primary keratinocytes. Immunocytochemical
staining of endogenously expressed SORBS2 and p16INK4A in primary human keratinocytes of the donor FK09-9 (A) at passage 5 and (B) at
passage 7 was performed. Strong endogenous expression of p16INK4a and SORBS2 correlated with a near senescent stage of the cells (B).
(a, c magnification ×100; b, d magnification ×200)
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nocytes analysed.
The observation that the endogenous expression of both
SORBS2 and TLR3 is increased drastically in primary kera-
tinocyte cultures at near senescent passage provides further
support that these genes may contribute to senescence. In
ongoing experiments we are investigating whether this in-
crease in gene expression is also characteristic of replicative
senescence. Moreover, modulation of both genes byshRNA-knockdown may result in a prolonged life-span of
keratinocytes in culture which would be another indication
for a physiological role of either protein in the senescence
process.
Conclusions
Of interest is the novel finding that SORBS2 and TLR3
can induce senescence in primary human fibroblasts
and keratinocytes but not in HPV-immortalized cell lines.
Liesenfeld et al. BMC Cancer 2013, 13:507 Page 10 of 11
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increases during finite passaging of primary keratinocytes
in vitro. The relevance of these genes in the process of
cellular senescence warrants further investigation.Additional files
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expand template PCR.
Additional file 5: Table S5. Primers for sequencing of cDNA-clones.
Additional file 6: Table S6. Validation with quantitative real-time PCR
and evaluation with REST [18] CIN3 vs. CxCa.
Additional file 7: Figure S1. Expression of candidate genes in CIN3
and cervical carcinomas (CxCa). Relative gene expression of WDR37,
PFKFB3, IL15RA, FBXO18, DIP2, CYPV2, PRKCQ, GATA3 was determined by
quantitative RT-PCR in CIN3 (n = 20) and CxCa (n = 20). For normalisation
the housekeeping genes GAPDH, HPRT and ACTB were used. With
exception of PFKFB3 the differences in gene expression were highly
significant (<0.001).
Additional file 8: Figure S2. Ectopic expression of SORBS2 in HPV-
immortalized cells. Beta-galactosidase staining was performed at different
time points after lentiviral transduction. Depicted are cells stained 14 days
after transduction of pCDH empty vector (control) and SORBS2-2.
Senescence could not be observed in HPKIAp83 and HPKIIp289 (B).
Controls were also negative (A). All images were captured at 200×
magnification. Expression of the transgene in cells at same passage was
confirmed by Western blot (C).
Additional file 9: Figure S3. Ectopic expression of TLR3 in primary
fibroblasts Beta-galactosidase staining was performed at different time
points after lentiviral transduction. Depicted are cells stained 14 days after
transduction of pCDH empty vector (control) and TLR3. Only a few
senescent cells are evident in the control (A). An at least 2-fold increase
in senescent cells was observed after transduction of TLR3 in primary
human fibroblasts (B). The images were captured at 200× magnification.
Expression of the transgene in cells at passage 1, 3 and 5 was confirmed
by Northern blot (C).
Additional file 10: Figure S4. Endogenous expression of TLR3 during
in vitro passaging of primary keratinocytes. Relative gene expression of
TLR3 in two different passages from three different donors (FK09-3 (A),
FK09-7 (B) and FK09-9 (C)) was determined by quantitative RT-PCR. For
normalisation the housekeeping genes GAPDH, HPRT and ACTB were
used. For all donors the relative expression of TLR3 is increased in the
later near- senescent passages.Competing interests
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